Anika Therapeutics, Inc. (ANIK)
19.10
-0.26
(-1.34%)
USD |
NASDAQ |
Oct 02, 16:00
19.12
+0.02
(+0.10%)
After-Hours: 20:00
Anika Therapeutics Profit Margin (Quarterly) : 10.15% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.15% |
| March 31, 2026 | -17.07% |
| December 31, 2025 | 5.88% |
| September 30, 2025 | -11.41% |
| June 30, 2025 | -16.47% |
| March 31, 2025 | -15.13% |
| December 31, 2024 | -8.12% |
| September 30, 2024 | -6.24% |
| June 30, 2024 | -8.27% |
| March 31, 2024 | -6.74% |
| December 31, 2023 | -7.85% |
| September 30, 2023 | -15.86% |
| June 30, 2023 | -6.19% |
| March 31, 2023 | -27.29% |
| December 31, 2022 | -12.39% |
| September 30, 2022 | -10.37% |
| June 30, 2022 | -7.17% |
| March 31, 2022 | -7.99% |
| December 31, 2021 | -16.17% |
| September 30, 2021 | 1.41% |
| June 30, 2021 | 17.12% |
| March 31, 2021 | 8.28% |
| December 31, 2020 | -47.90% |
| September 30, 2020 | -20.23% |
| June 30, 2020 | -25.13% |
| Date | Value |
|---|---|
| March 31, 2020 | 16.37% |
| December 31, 2019 | 13.61% |
| September 30, 2019 | 30.98% |
| June 30, 2019 | 31.02% |
| March 31, 2019 | 18.23% |
| December 31, 2018 | 28.63% |
| September 30, 2018 | 28.37% |
| June 30, 2018 | 33.04% |
| March 31, 2018 | -31.44% |
| December 31, 2017 | 27.45% |
| September 30, 2017 | 25.33% |
| June 30, 2017 | 33.98% |
| March 31, 2017 | 23.49% |
| December 31, 2016 | 28.15% |
| September 30, 2016 | 34.71% |
| June 30, 2016 | 32.41% |
| March 31, 2016 | 30.94% |
| December 31, 2015 | 35.74% |
| September 30, 2015 | 35.39% |
| June 30, 2015 | 34.14% |
| March 31, 2015 | 22.65% |
| December 31, 2014 | 33.61% |
| September 30, 2014 | 27.98% |
| June 30, 2014 | 35.40% |
| March 31, 2014 | 44.19% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Precigen, Inc. | 36.51% |
| Repligen Corp. | 2.45% |
| Amgen, Inc. | 23.59% |
| Biogen, Inc. | 3.72% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.20% |
| Return on Assets | -1.66% |
| Return on Invested Capital | -1.87% |
| Gross Profit Margin (Quarterly) | 65.15% |
| Operating Margin (Quarterly) | 9.06% |
| Return on Net Operating Assets | -2.57% |